LCAT antibody (N-Term)
Quick Overview for LCAT antibody (N-Term) (ABIN630433)
Target
See all LCAT AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- LCAT antibody was raised against the N terminal of LCAT
-
Purification
- Purified
-
Immunogen
- LCAT antibody was raised using the N terminal of LCAT corresponding to a region with amino acids MGPPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVI
-
-
-
-
Application Notes
-
WB: 5 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
LCAT Blocking Peptide, (ABIN5614425), is also available for use as a blocking control in assays to test for specificity of this LCAT antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of LCAT antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- LCAT (Lecithin-Cholesterol Acyltransferase (LCAT))
-
Alternative Name
- LCAT
-
Background
- LCAT is an extracellular cholesterol esterifying enzyme, lecithin-cholesterol acyltransferase. The esterification of cholesterol is required for cholesterol transport. Mutations in its gene have been found to cause fish-eye disease as well as LCAT deficiency.
-
Molecular Weight
- 48 kDa (MW of target protein)
-
Pathways
- Lipid Metabolism
Target
-